Cover Image

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma

Show other versions (1)

Background: The addition of rituximab (R) to CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) -like therapy has improved survival in primary mediastinal B-cell lymphoma (PMBCL) patients. However, these results were obtained in young low risk patients and a reevaluation in an unselect...

Full description

Saved in:
Bibliographic Details
Main Authors: Kriegsmann, Katharina (Author) , Cremer, Martin (Author) , Kriegsmann, Mark (Author) , Ho, Anthony Dick (Author) , Witzens-Harig, Mathias (Author)
Format: Article (Journal)
Language:English
Published: 22 May 2017
In: BMC cancer
Year: 2017, Volume: 17
ISSN:1471-2407
DOI:10.1186/s12885-017-3332-3
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12885-017-3332-3
Verlag, kostenfrei, Volltext: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440917/
Get full text
Author Notes:K. Lisenko, G. Dingeldein, M. Cremer, M. Kriegsmann, A.D. Ho, M. Rieger and M. Witzens-Harig
Search Result 1
Cover Image

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma by Kriegsmann, Katharina (Author) , Dingeldein, Günther (Author) , Cremer, Martin (Author) , Kriegsmann, Mark (Author) , Ho, Anthony Dick (Author) , Rieger, Michael (Author) , Witzens-Harig, Mathias (Author) ,

BioMed Central; Springer 2017

Get full text
Article (Journal) Book/Monograph Online Resource

Saved in:
Show all versions (2)

Similar Items